Simultaneously, the nanosystem was used to deliver siRNA targeting MDR1, also known as P-gp, which is a cell membrane protein responsible for the drug resistance of tumor cells (by pumping out anticancer drugs and preventing their intracellular accumulation). Here, PGP is linked to neoplasm.